2-((2-(Indolin-1-yl)-2-oxoethyl)thio)-N-(6-methoxy-3-(2-methoxyethyl)benzo[d]thiazol-2(3H)-ylidene)acetamide

Catalog No. :
ACSMBE320
CAS No. :
851716-91-1
Molecular Formula :
C23H25N3O4S2
Molecular Weight :
471.60

IUPAC Name:(E)-2-((2-(indolin-1-yl)-2-oxoethyl)thio)-N-(6-methoxy-3-(2-methoxyethyl)benzo[d]thiazol-2(3H)-ylidene)acetamide

2-((2-(Indolin-1-yl)-2-oxoethyl)thio)-N-(6-methoxy-3-(2-methoxyethyl)benzo[d]thiazol-2(3H)-ylidene)acetamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-((2-(Indolin-1-yl)-2-oxoethyl)thio)-N-(6-methoxy-3-(2-methoxyethyl)benzo[d]thiazol-2(3H)-ylidene)acetamide
IUPAC Name(E)-2-((2-(indolin-1-yl)-2-oxoethyl)thio)-N-(6-methoxy-3-(2-methoxyethyl)benzo[d]thiazol-2(3H)-ylidene)acetamide
Molecular FormulaC23H25N3O4S2
Molecular Weight471.60
SMILESCOCCN1/C(=N\C(=O)CSCC(=O)N2CCC3=C2C=CC=C3)SC2=CC(OC)=CC=C21
InChI KeyJKFIUDKMVLZTJT-WCWDXBQESA-N
Synonym(Z)-2-((2-(indolin-1-yl)-2-oxoethyl)thio)-N-(6-methoxy-3-(2-methoxyethyl)benzo[d]thiazol-2(3H)-ylidene)acetamide;Acetamide, 2-[[2-(2,3-dihydro-1H-indol-1-yl)-2-oxoethyl]thio]-N-[6-methoxy-3-(2-methoxyethyl)-2(3H)-benzothiazolylidene]-
CAS No.851716-91-1

Synthetic Route by SureRoute

1. ACSMBE320 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACITKQ649 route compound structure diagram
    ACITKQ649496-15-1 In Stock
  4. Then
  5. ACSMBE320 route product structure diagram
    ACSMBE320851716-91-1
Inquiry

2. ACSMBE320 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACSMBE320 route product structure diagram
    ACSMBE320851716-91-1
Inquiry

Comments (0)